SANION
Sanion is a specialized energy company that offers integrated solutions, produces and supplies IT devices.
SANION
Industry:
Electrical Distribution Energy Supply Chain Management
Founded:
1997-08-28
Address:
Incheon, Inch'on-jikhalsi, South Korea
Country:
South Korea
Website Url:
http://www.sanion.com
Status:
Active
Contact:
032-230-0500
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API Apple Mobile Web Clips Icon Content Delivery Network Mobile Non Scaleable Content Nginx JsDelivr Sectigo SSL
Official Site Inspections
http://www.sanion.com
- Host name: 183.111.161.238
- IP address: 183.111.161.238
- Location: South Korea
- Latitude: 37.5112
- Longitude: 126.9741
- Timezone: Asia/Seoul
More informations about "Sanion"
SANION
Renewal of Sanion's Homepage SANION Co., Ltd. CEO : LEE DONG RYUL Business license number : 213-86-32795 Address : 13 Gumdan-ro 114, Seo-gu, Incheon Tel : +82 32-230-0500 …See details»
Sanion - Crunchbase Company Profile & Funding
Organization. Sanion . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. ... Sanion is located in Incheon, Inch'on-jikhalsi, South Korea. Who are …See details»
Saniona Announces Strategic Program Prioritization and …
PRESS RELEASE March 29, 2022 Saniona (OMX: SANION), a clinical-stage biopharmaceutical company focused on rare diseases, today announced a strategic program reprioritization and …See details»
SANION
SANION. Company. CEO Message; Overview; Vision; History; Organization; Certification; Location; Substation Automation. System; Protection Panel. Transmission line ...See details»
Saniona Announces Strategic Program Prioritization and
Mar 29, 2022 Saniona (OMX: SANION), a clinical-stage biopharmaceutical company focused on rare diseases, today announced a strategic program reprioritization and restructuring intended …See details»
Saniona AB (publ) (STO: SANION) Company Profile & Overview
Nov 22, 2024 Saniona AB (publ), a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of treatments for rare disease patients in …See details»
Saniona - Crunchbase Company Profile & Funding
Saniona is a pharmaceutical company focusing on the development and advancement of multiple potential new medicines through clinical trials. The company is pioneering in the development of highly selective ion channel …See details»
Saniona received approximately USD $2.9 million (SEK 24.2 million ...
PRESS RELEASE January 25, 2021 Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on rare diseases, today announced it received approximately USD $2.9 …See details»
Saniona Announces Refocused Strategy on Ion Channel R&D and
Apr 25, 2022 Saniona (OMX: SANION), a clinical-stage biopharmaceutical company focused on rare diseases, today announced that it will refocus its strategy on ion channel research and …See details»
Saniona publishes its Annual Report for 2020 - GlobeNewswire
Apr 29, 2021 Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on rare diseases, today announced that the English version of the Annual Report for 2020 is now …See details»
Saniona Receives U.S. FDA Orphan Drug Designation for Tesomet …
Jul 26, 2021 Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on rare diseases, today announced that the U.S. Food and Drug Administration (FDA) has …See details»
Saniona Hosts Research and Development (R&D) Day on
May 20, 2021 Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on rare diseases, today announced that it hosted a virtual R&D day event, during which it …See details»
Saniona provides update on outstanding option programs - Nasdaq
Aug 5, 2022 Saniona (OMX: SANION), a clinical stage biopharmaceutical company, today announced that 6,450,734 options have forfeited in 2022, leading to a reduction in potential …See details»
Saniona Announces Refocused Strategy on Ion Channel R&D and ...
Apr 25, 2022 Saniona (OMX: SANION), a clinical-stage biopharmaceutical company focused on rare diseases, today announced that it will refocus its strategy on ion channel research and …See details»
Saniona Initiates Phase 1 Clinical Trial of SAN711 - Yahoo Finance
PRESS RELEASE June 30, 2021 Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on rare diseases, today announced that it has dosed the first patient in a …See details»
Saniona Initiates Phase 1 Clinical Trial of SAN711 - BioSpace
June30, 2021. Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on rare diseases, today announced that it has dosed the first patientin a Phase 1 clinical trial of …See details»
Saniona appoints Wendy Dwyer as Chief Business Officer
PRESS RELEASE 15 September 2021 Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on rare diseases, today announced the appointment of …See details»
Saniona Hosts Research and Development (R&D) Day on …
May 20, 2021 Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on rare diseases, today announced that it hosted a virtual R&D day event, during which it …See details»
Saniona Initiates Phase 1 Clinical Trial of SAN711 - GlobeNewswire
Jun 30, 2021 Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on rare diseases, today announced that it has dosed the first patient in a Phase 1 clinical trial of …See details»